Extended: GLP-1 Bone Health Panel (Quest)

What this panel includes

• Collagen cross linked N telopeptide (NTx), urine: A marker of bone resorption and turnover, used to assess changes in bone metabolism over time

Why patients choose this

• A non-invasive, radiation-free way to assess bone turnover while on GLP-1 therapy, using a urinary NTx marker.
• Helpful for tracking trends in bone health over time as weight and body composition change.
• A lower-burden option that may be used as an alternative or adjunct to imaging-based bone density or body composition assessments.
• Optional, for individuals who want to monitor bone health alongside long-term metabolic therapy.
• Schedule your lab test seamlessly and complete it at a lab near you.

Before your test

It is recommended to fast for at least 8 hours before.

Important information

Why it matters: GLP-1 therapies can drive significant weight loss and changes in body composition, and rapid or sustained weight loss may influence bone turnover, making thoughtful monitoring an important part of long-term care.

Who it's for: optional, and especially useful for those seeking a lower-burden, radiation-free option to monitor bone health while on GLP-1 therapy.

Results are interpreted alongside symptoms, weight trajectory, nutritional status, and overall clinical context. Lab values alone do not dictate treatment decisions.

It is recommended to fast for at least 8 hours before your draw.